{
  "pmcid": "8923580",
  "sha256": "6ff04fb2414c7a60166b6c45af3ace6ec66486fd72df4d7162760a1edbc3b4da",
  "timestamp_utc": "2025-11-10T00:11:12.241704+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.426694271911664,
    "reading_ease": 46.99270186335406,
    "word_count": 252
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of US-Guided Steroid Injections in de Quervain Disease"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "A sample size of 21 per group was calculated to provide 80% power to detect a clinically important difference of 20 mm in VAS score."
      },
      "Participants": {
        "score": 2,
        "evidence": "50 patients with de Quervain disease and complete intracompartmental septum were randomised"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive US-guided injections in both subcompartments (n = 25) or the EPB subcompartment alone (n = 25)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial evaluated the effectiveness and safety of US-guided steroid injections"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pain reduction measured by VAS score at 6 weeks."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "50 patients with de Quervain disease and complete intracompartmental septum were randomised"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "mean difference -0.08, 95% CI -4.08 to 3.91; p = 0.97"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events such as tendon rupture or infections occurred."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}